Technologies at Medical Technology Startups This Month

1 Mins read

Here’s a preliminary list of the technologies at companies we have identified this month to date (16 Sept. 2011) and included in the Medtech Startups Database:

Here’s a preliminary list of the technologies at companies we have identified this month to date (16 Sept. 2011) and included in the Medtech Startups Database:

  • Hydrogel-based tissue expanders.
  • Systems to prepare tissue for prosthetic implants and grafts.
  • Implants for internal compression or distraction of, for example, bone fractures, fusions, and osteotomies.
  • Devices for heart and vascular, initially developing a catheter-delivered heart valve.
  • Imaging and microfluidics based system to detect cancer.
  • System for detecting pressure-induced ischemia to assist in prevention and treatment of pressure ulcers.
  • Fentanyl iontophoretic transdermal drug delivery system.
  • Implants and other devices for treatment of injured or damaged shoulders.

MedMarket Diligence offers an online, searchable database of medical technology company startups. Updated regularly with addition of at least 10 new companies per month, the Medtech Startups Database contains contact details, business/product/technology descriptions and other data with records searchable by keyword and categorized by clinical/technology segment. Currently the database contains approximately 1,000 medical technology startup companies spanning medical device, biotech, biomaterials, diagnostics, pharmaceuticals and other medical product companies. 


Until September 30, 2011, get any MedMarket Diligence report (any option: single user, site license or global license) for 20% off.  Order online (or any “online order” link) and use coupon code 1315780157 on checkout to receive a 20% discount.


183 posts

About author
I serve the interests of medical technology company decision-makers, venture-capitalists, and others with interests in medtech producing worldwide analyses of medical technology markets for my audience of mostly medical technology companies (but also rapidly growing audience of biotech, VC, and other healthcare decision-makers). I have a small staff and go to my industry insiders (or find new ones as needed) to produce detailed, reality-grounded analyses of current and potential markets and opportunities. I am principally interested in those core clinical applications served by medical devices, which are expanding to include biomaterials, drug-device hybrids and other non-device technologies either competing head-on with devices or being integrated with devices in product development. The effort and pain of making every analysis global in scope is rewarded by my audience's loyalty, since in the vast majority of cases they too have global scope in their businesses. Specialties: Business analysis through syndicated reports, and select custom engagements, on medical technology applications and markets in general/abdominal/thoracic surgery, interventional cardiology, cardiothoracic surgery, patient monitoring/management, wound management, cell therapy, tissue engineering, gene therapy, nanotechnology, and others.
Related posts

New Medical Laboratories Are the Key to Diagnostics Research

3 Mins read
The development of the COVID-19 vaccine was a miracle in medical research. It shows the incredible importance of medical innovation in the…

How Rapid Blood Testing Solves Blood Lab Wait Time Issues

3 Mins read
In early November 2020, Steven Hill* experienced a concerning and prolonged bout of nausea, weakness, and a host of other symptoms that…
Health careMedical DevicesTechnology

Can Medical Devices Help Reduce the Cost of Healthcare?

8 Mins read
Healthcare costs are on the rise; according to CNN Money, a 2016 report reveals the huge cost gap between the early 2000s…